Table 2. Results of the exercise performance in the population in study.
CRF patients#(n = 40) | Controls#(n = 35) | Controls in room air(n = 35) | |||||||
No-Aid | Aid | p | No-Aid | Aid | p | No-Aid | Aid | p | |
Distance walked at 6MWT, meters | 295.2 (90.8) | 318.7 (90.0) | 0.003 | 506.2 (50.5) | 482.1 (43.6) | <0.001 | 501.0 (54.4) | 484.2 (43.5) | 0.002 |
Distance walked at 6MWT, % predicted | 61.4 (17.8) | 67.5 (19.0) | 0.003 | 110.9 (14.1) | 103.9 (13.8) | <0.001 | 109.1 (14.9) | 105.2 (13.4) | <0.001 |
Peak effort dyspnoea, Borg† | 4.67 (2.0) | 3.81(1.8) | <0.001 | 1.28 (0.7) | 1.51 (0.7) | 0.053 | 1.14 (0.7) | 1.48 (0.7) | 0.005 |
Peak leg effort fatigue, Borg† | 3.60 (1.8) | 2.65 (1.2) | <0.001 | 1.40 (0.7) | 1.59 (0.7) | 0.076 | 1.31 (0.9) | 1.53 (0.7) | 0.024 |
RR at peak effort, breaths/min | 22.8 (4.1) | 21.6 (3.2) | <0.001 | 18.7 (1.7) | 19.1 (2.0) | 0.051 | 18.7 (2.3) | 19.4 (2.2) | 0.001 |
HR max, beats/min | 109.2 (9.9) | 106.1 (11.5) | 0.067 | 105.4 (9.2) | 105.0 (11.4) | 0.751 | 106.5 (10.2) | 110.6 (10.7) | 0.036 |
SaO2 pre-test, % | 94.1 (2.3) | 94.8 (1.8) | 0.601 | 97.4 (1.0) | 97.6 (0.8) | 0.905 | 95.6 (1.3) | 95.7 (1.3) | 0.231 |
SaO2, % | 88.7 (3.3) | 89.4 (3.8) | 0.060 | 95.5 (1.1) | 95.4 (0.9) | 0.497 | 94.0 (1.1) | 93.5 (1.2) | 0.001 |
Reduction of SaO2 during 6MWT, % | 5.35 (2.8) | 5.36 (3.6) | 0.990 | 1.86 (1.1) | 2.24 (1.0) | 0.049 | 1.62 (1.0) | 2.20 (1.2) | <0.001 |
Nadir of SaO2 during 6MWT, % | 84.1 (5.9) | 85.5 (5.8) | 0.019 | 93.7 (1.5) | 93.7 (1.8) | 0.926 | 91.4 (1.9) | 91.6 (1.8) | 0.546 |
Value expressed as mean ± SD.
Test performed breathing oxygen at 3 L/min.
Differences calculated using no-parametric test of Kruskal-Wallis and Wilcoxon test.